Canadian Omy Laboratoratories, a technology-enabled personalized dermo-cosmetic range, has landed an $11 million investment round led by Crédit Mutuel Equity.
WHO: Established in 2018, Quebec City-based Omy Laboratories uses advanced diagnostics and 3D skin analysis technology to provide personalized high-performance dermo-cosmetic products. Omy uses 95% naturally sourced and 100% vegan ingredients, and strives to make its packaging eco-friendly by using bio-based, recyclable plastic, or recycled materials by the end of 2023.
WHY: The funds will be used to build the team, invest in production infrastructure, and expand in the US market.
IN THEIR OWN WORDS: "Skin care is not just about aesthetics, and Omy, which offers safe products adapted to each individual, understands this very well. Through the integration of cosmetic chemistry and artificial intelligence, Omy offers a precise personalization of its skin care products. The company's eco-responsible approach, natural products not tested on animals and entrepreneurial drive are all features that align with our positioning in the Health and Wellness space," said Claire Bisson, Deputy Head of Investment, Impact and Sustainable Investment at Fondaction.
"We are proud to support Omy Laboratoires in its quest to conquer global markets. This innovative company, led by two visionary women entrepreneurs, fits perfectly with Accelia Capital's mission of promoting diversity, performance and impact," said Annick Charbonneau, co-founder and Managing Partner, Accelia Capital.
''Omy Laboratoires' already well-established brand and innovative products are positioning the business in strong posture for its next phase of expansion in new markets,'' said Michelle Scarborough, Managing Partner, Thrive Venture Fund at BDC Capital. ''We're very proud to participate in the company's first financing round and support them in their ambitious vision.''
DETAILS:
